19937 results for «»
19937 results
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Author
Repeat NSTEMI late after self-expanding TAVR
17 May 2022 – From EuroPCR 2022
Discover the case of a 79 year-old man presenting to the ER with NSTEMI and chest pain, with an history of NSTEMI with PCI and TAVR (CTO of the dominated RCA and intermediate stenosis of the proximal LAD). Angiography reveals a tight stenosis of proximal and...
RTC - Radial versus femoral access for coronary procedures
29 Aug 2022
Thirty years after the first radial access interventional coronary procedure the RTC trial provides evidence that radial access for coronary angiography or PCI is associated with lower risks of all-cause death and bleeding compared with femoral access. Mirvat Alasnag interviews Giuseppe Gargiulo regarding the methodology and...

Author

Author
Severe coronary calcification: a setting for more than one lesion preparation method
17 May 2022 – From EuroPCR 2022
Discover the case of a 85 year-old male patient with an inferior NSTEMI, a severely reduced LVEF 20%, a symptomatic COVID-19 infection and various comorbidities. The RCA subocclusion was successfully stented, while the predilation of the proximal LAD calcification remained unsuccessful. How did the team treat...
The freaky and rocky road
17 May 2022 – From EuroPCR 2022
Discover the case of a 85 year-old female patient presenting with angina during dialysis and LVEF 55% with hypokinesia in inferior wall. Angiogram reveals an anomalous RCA from left sinus with a mid-RCA calcified CTO. Watch the video to learn more about the treatment's option!
PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction
28 Aug 2022
Ali Nazmi Calik asks trial investigator John Alexander about the design and results of the PACIFIC-AMI phase 2 trial, which revealed no increase in bleeding versus placebo.

Author
Author
Treatment of atherosclerotic vasospastic plaque in proximal left anterior descending and left main
17 May 2022 – From EuroPCR 2022
Discover the case of a 57 year-old male patient presenting with chest pain, ECG-ST segment depression in all precordial leads and elevated HS troponins. He already suffered from this event 2 years ago (treated conservatively). Angiogram reveals a vasospastic atherosclerotic plaque in proximal LAD and LM....
INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation
28 Aug 2022
Aaysha Cader interviews Ganesan Karthikeyan who presented the results of INVICTUS during the ESC Congress 2022 in Barcelona: Among patients with rheumatic heart disease–associated atrial fibrillation, vitamin K antagonist therapy led to a lower rate of a composite of cardiovascular events or death than rivaroxaban therapy,...

Author

Author
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Author
New insights in coronary artery disease and OHCA
17 May 2022 – From EuroPCR 2022
Consult this session to gain insights into coronary artery disease and OHCA: learn about the 4-year clinical outcomes of the RESTORE SVD trial regarding the Restore DCB, the results of the FAVOR III trial comparing QFR-guided vs angiography-guided PCI in patients with MVD, and more!
DANFLU-1 - High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults
28 Aug 2022
Tor Biering-Sørensen talks with Aaysha Cader about the results of the DANFLU-1 trial which were presented during ESC Congress 2022 in Barcelona. In fact, elderly adults who received a high-dose quadrivalent influenza vaccine compared with a standard dose saw significantly reduced risk of death and hospitalization...

Author

Author
Relative survival after mitral TEER in MitraSwiss patients
28 Aug 2022
Mirvat Alasnag interviews Luigi Biasco, first author of the MitraSwiss Registry which was presented at the ESC Congress 2022 in Barcelona. Together, they discuss the enrolled population, the inclusion criteria, the design and outcomes of MitraSwiss, its comparison with other European registries and the restoration of...

Author

Author
Peripheral Interventions
17 May 2022 – From EuroPCR 2022
Watch this video to learn more about the rationale, design and status of the SirPAD phase III randomized controlled trial, investigating whether the use of sirolimus-coated balloon catheters in patients with peripheral artery disease is not inferior to that of uncoated balloon catheters for major clinical...
TAVI - New insights
17 May 2022 – From EuroPCR 2022
Watch this session to learn about the latest studies regarding TAVI, and gain insights into paravalvular leakage 5 years post-TAVI, infective endocarditis after TAVI, survival and structural valve degeneration in first generation transcatheter aortic valves, and more!
What do we know about tricuspid valve disease? A case-based webinar series
04 Aug 2022
These 3 innovative PCR Webinars are the work of the PCR Tricuspid Focus Group. To learn more about this initiative’s mission and its five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease, please click here.
Learning objectivesView this series of 3 case-based webinars if...
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
25 Aug 2022
In this post-hoc analysis of the TWILIGHT trial, the authors report the effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients with prior CABG at least three months post PCI with no adverse events and at least one clinical and one angiographic high-risk feature...

Reviewer
Natural history and prognosis of tricuspid valve disease
04 Aug 2022
PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky
Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)
09 Aug 2022
The ST-OHCA study is a single centre prospective study investigating the incidence, timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest (OHCA) undergoing immediate PCI and therapeutic hypothermia.

Reviewer
Clinical Cases on Peripheral Interventions - Part 1
17 May 2022 – From EuroPCR 2022
Consult this session to discover a selection of cases on peripheral interventions: peripheral angioplasty for gangrenous left ring finger with septicaemia, dangerous leaks in thoracic aortic aneurysm secondary to ataphylococcus aureus, and much more!
Tricuspid valve interventions: patient and device selection
09 Aug 2022
PCR Webinar on tricuspid valve disease with F. Maisano, R. von Bardeleben, J. L. Zamorano, J. Cavalcante, P. Lurz and G. Nickenig